During the past decade, Paracelsus-Krankenhaus Ruit conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paracelsus-Krankenhaus Ruit" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 3 trials, followed by "German CLL Study Group" with 2 trials sponsored, "University Hospital Tuebingen" with 2 trials sponsored, "Aesculap AG" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paracelsus-Krankenhaus Ruit" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Central European Cooperative Oncology Group" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "German Association of Urologic Oncology" with 1 trials as a collaborator and "Groupe D'Etude des Tumeurs Uro-Genitales" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Paracelsus-Krankenhaus Ruit" are "Cholangiocarcinoma" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Gallbladder Cancer" (2 trials), "Hepatocellular Cancer" (2 trials) and "Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Paracelsus-Krankenhaus Ruit" in a lesser frequency.

Most popular intervention types in "Paracelsus-Krankenhaus Ruit" are "Drug" (6 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials), "Bendamustine" (1 trials), "Blood sampling" (1 trials) and "EinsteinVision 3D visualization system" (1 trials). Other intervention names were less common.

The vast majority of trials in "Paracelsus-Krankenhaus Ruit" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Paracelsus-Krankenhaus Ruit". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Paracelsus-Krankenhaus Ruit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Paracelsus-Krankenhaus Ruit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".